JPI-547, a Dual Inhibitor of PARP/tankyrase, Shows antitumor activity against pancreatic cancers with homologous recombination repair deficiency or Wnt-Addiction
Home »
Publications » JPI-547, a Dual Inhibitor of PARP/tankyrase, Shows antitumor activity against pancreatic cancers with homologous recombination repair deficiency or Wnt-Addiction
Publish Date 10/06/2025
Category
Keywords
JPI-547, a Dual Inhibitor of PARP/tankyrase, Shows antitumor activity against pancreatic cancers with homologous recombination repair deficiency or Wnt-Addiction
Join the Arbor Assays Newsletter
Sign up for Arbor Assays’ email list to stay up to date on special deals, new kits, and published articles featuring Arbor Assays’ products
